News
FDA bans use of Lilly, Regeneron COVID drugs due to Omicron
The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the back of data suggesting they have are "highly unlikely" to be effective against the n
